综述

CRISPR/Cas9基因组编辑技术在癌症研究中的应用

展开
  • 1. 哈尔滨医科大学生物化学与分子生物学教研室,哈尔滨 150086;
    2. 哈尔滨医科大学北方转化医学研究合作中心,哈尔滨 150086;
    3. 黑龙江省医学科学院,哈尔滨 150086
王大勇,博士,专业方向:遗传改变模式动物的建立及复杂疾病机制研究。

收稿日期: 2015-08-31

  修回日期: 2015-11-20

  网络出版日期: 2016-01-20

基金资助

国家自然基金项目(编号:81270511, 81200827)资助

The application of CRISPR/Cas9 genome editing technology in cancer research

Expand
  • 1. Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin 150086, China;
    2. Translational Medicine Research and Cooperation Center of Northern China, Harbin Medical University, Harbin 150086, China;
    3. Heilongjiang Academy of Medical Sciences, Harbin 150086, China

Received date: 2015-08-31

  Revised date: 2015-11-20

  Online published: 2016-01-20

Supported by

[Supported by the National Natural Science Foundation of China (Nos; 81270511, 81200827)]

摘要

CRISPR/cas9基因组编辑技术因其设计简单以及操作容易,使其在基因编辑的研究中越来越受到欢迎。利用该技术,科研人员可以实现在碱基的水平对基因组进行定点修饰。CRISPR系统现已经被广泛地应用到多个物种的基因组编辑以及癌症的相关研究中。本文在最新研究进展的基础上,结合对癌症研究及基因组编辑技术的理解,对CRISPR/Cas9技术在癌症研究中的应用进行了综述。

本文引用格式

王大勇, 马宁, 惠洋, 高旭 . CRISPR/Cas9基因组编辑技术在癌症研究中的应用[J]. 遗传, 2016 , 38(1) : 1 -8 . DOI: 10.16288/j.yczz.15-252

Abstract

The CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein-9 nuclease) genome editing technology has become more and more popular in gene editing because of its simple design and easy operation. Using the CRISPR/Cas9 system, researchers can perform site-directed genome modification at the base level. Moreover, it has been widely used in genome editing in multiple species and related cancer research. In this review, we summarize the application of the CRISPR/Cas9 system in cancer research based on the latest research progresses as well as our understanding of cancer research and genome editing techniques.

参考文献

[1] Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol , 1987, 169(12): 5429-5433.
[2] Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science , 2014, 346(6213): 1258096.
[3] Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell , 2014, 157(6): 1262-1278.
[4] Wang HY, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell , 2013, 153(4): 910-918.
[5] Yang H, Wang HY, Shivalila CS, Cheng AW, Shi LY, Jaenisch R. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell , 2013, 154(6): 1370-1379.
[6] Zhou XQ, Xin JG, Fan NN, Zou QJ, Huang J, Ouyang Z, Zhao Y, Zhao BT, Liu ZM, Lai SS, Yi XL, Guo L, Esteban MA, Zeng YZ, Yang HQ, Lai LX. Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer. Cell Mol Life Sci , 2015, 72(6): 1175-1184.
[7] Wan HF, Feng CJ, Teng F, Yang SH, Hu BY, Niu YY, Xiang AP, Fang WZ, Ji WZ, Li W, Zhao XY, Zhou Q. One-step generation of p53 gene biallelic mutant Cynomolgus monkey via the CRISPR/Cas system. Cell Res , 2015, 25(2): 258-261.
[8] Zhao P, Zhang Z, Ke HM, Yue YR, Xue D. Oligonucleotide-based targeted gene editing in C. elegans via the CRISPR/Cas9 system. Cell Res , 2014, 24(2): 247-250.
[9] Hruscha A, Krawitz P, Rechenberg A, Heinrich V, Hecht J, Haass C, Schmid B. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Development , 2013, 140(24): 4982-4987.
[10] Hwang WY, Fu YF, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JRJ, Joung JK. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol , 2013, 31(3): 227-229.
[11] Shan QW, Wang YP, Li J, Zhang Y, Chen KL, Liang Z, Zhang K, Liu JX, Xi JZJ, Qiu JL, Gao CX. Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol , 2013, 31(8): 686-688.
[12] Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, Nureki O, Zhang F. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature , 2015, 517(7536): 583-588.
[13] Bikard D, Jiang WY, Samai P, Hochschild A, Zhang F, Marraffini LA. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res , 2013, 41(15): 7429-7437.
[14] Liu T, Li YJ, Wang XD, Ye Q, Li H, Liang YX, She QX, Peng N. Transcriptional regulator-mediated activation of adaptation genes triggers CRISPR de novo spacer acquisition. Nucleic Acids Res , 2015, 43(2): 1044-1055.
[15] Zhou JW, Xu QB, Yao J, Yu SM, Cao SZ. CRISPR/Cas9 genome editing technique and its application in site-directed genome modification of animals. Hereditas (Beijing) , 2015, 37(10): 1011-1020. 周金伟, 徐绮嫔, 姚婧, 余树民, 曹随忠. CRISPR/Cas9基因组编辑技术及其在动物基因组定点修饰中的应用. 遗传, 2015, 37(10): 1011-1020.
[16] Kraft K, Geuer S, Will AJ, Chan WL, Paliou C, Borschiwer M, Harabula I, Wittler L, Franke M, Ibrahim DM, Kragesteen BK, Spielmann M, Mundlos S, Lupiáñez DG, Andrey G. Deletions, inversions, duplications: engineering of structural variants using CRISPR/Cas in mice. Cell Rep , 2015, 10(5): 833-839, doi:10.1016/ j.celrep. 2015.01.016.
[17] Stell A, Biserni A, Della Torre S, Rando G, Ramachandran B, Ottobrini L, Lucignani G, Maggi A, Ciana P. Cancer modeling: modern imaging applications in the generation of novel animal model systems to study cancer progression and therapy. Int J Biochem Cell Biol , 2007, 39(7-8): 1288-1296.
[18] van Dy
文章导航

/